Credit: Shutterstock photoChairman and CEO of C.r. Bard Inc ( BCR ) Timothy M Ring sold --…,……… shares of BCR on …9/-6/-…-6 at an average price of $--8.96 a share. The total sale was $-5.- million.
CR Bard Inc manufactures, distributes and sells medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, and extended care facilities. C.r. Bard Inc has a market cap of $-6.79 billion; its shares were traded at around $--8.59 with a P/E ratio of 5'.54 and P/S ratio of 4.85. The dividend yield of C.r. Bard Inc stocks is ….4'%. C.r. Bard Inc had an annual average EBITDA growth of 8.5…% over the past -… years. GuruFocus rated C.r. Bard Inc the business predictability rank of --star .
CEO Recent Trades:
- Chairman and CEO Timothy M Ring sold --…,……… shares of BCR stock on …9/-6/-…-6 at the average price of $--8.96. The price of the stock has decreased by ….-6% since.
Directors and Officers Recent Trades:
- VP - Human Resources Betty D Larson sold 4,…'- shares of BCR stock on …9/-9/-…-6 at the average price of $--5.''. The price of the stock has increased by -.45% since.
- Sr. VP, Gen Counsel & Secy. Samrat S. Khichi sold 9,-8' shares of BCR stock on …9/…6/-…-6 at the average price of $---.…-. The price of the stock has increased by '.4'% since.
- Sr. VP Sci Tech and Clin Afrs John A Deford sold 7,9-8 shares of BCR stock on …9/…6/-…-6 at the average price of $---.…6. The price of the stock has increased by '.4-% since.
For the complete insider trading history of BCR, click here
.About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
